SECsense Logo

Virpax Pharmaceuticals' 8-K Report: Key Financial Insights & Updates

$VRPX
Form 8-K
Filed on: 2025-01-07
Source
Virpax Pharmaceuticals' 8-K Report: Key Financial Insights & Updates

Based on the provided section of the financial report, here are the key insights:

  1. Entity Information:
  • Company Name: Virpax Pharmaceuticals, Inc.
  • CIK (Central Index Key): 0001708331
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-40064
  • Tax ID: 82-1510982
  • Address: 1055 Westlakes Drive, Suite 300, Berwyn, PA 19312
  • Phone Number: (610) 727-4597
  1. Filing Type:
  • Form Type: 8-K (Current Report)
  1. Report Date:
  • Filing Date: January 6, 2025
  1. Shares Information:
  • Common Stock Par Value: $0.00001 per share
  • Stock Symbol: VRPX
  • Exchange: NASDAQ
  1. Context and Reporting Period:
  • Reporting Date: January 6, 2025
  • The report appears to be as of the same date, indicating that it is a current snapshot of the company's financial status.
  1. Measurement Units:
  • Financial figures are reported in US Dollars (USD).
  • Shares are also being used as a unit of measurement indicating potential share metrics in the report.

Summary:

Virpax Pharmaceuticals, Inc. filed an 8-K report on January 6, 2025, detailing information relevant to its operations and financial position. The company is incorporated in Delaware and trades on NASDAQ under the symbol VRPX. The report includes critical details such as the company's address, contact information, and share structure, indicating a focus on its common stock.